Usually finding a target in LD-SCLC (limited disease, small cell lung cancer) is not a problem.  The early days was very much cookie-cutter including both above clavicle regions, both hila and down to diaphragm.  When the Intergoup trial was conceived in the late 80's, there was a nee...